Skip to Main Content

COVID-19 Intelligence Report: Pulmonary

May 11, 2020

Title: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

Publisher: NEJM

Publication Date: 07 May 2020

URL: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2006923

Key Takeaways: As you saw in last week’s Intelligence Report, there has been a debate over the association of ACE inhibitors and increased risk of developing COVID or having a more severe disease course. This large observational study does not support this theory and supports the safety of using ACE inhibitors in COVID patients.